newsfilter
← Latest News
GlobeNewswire·

Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates

—Regulatory filing of first-in-human (FIH) trial of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) anticipated in the second half of 2024 —Preclinical data presented at the American Thoracic Society